Outlook Therapeutics, Inc. (OTLK) dividend history
OTLKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/30
$0.36−0.04 (-8.94%)
Close on Nov 17, 2026Market cap $87.79MP/E –Yield –
Dividends
Outlook Therapeutics has not reported a dividend
No dividend per share appears in Outlook Therapeutics's annual filings since fiscal 2014.
See a number that looks wrong?